Marketing Collateral

Marketing collateral. These are the tangible materials sales teams use to communicate value propositions, substantiate claims, and guide stakeholders towards more informed purchase decisions. They articulate benefits clearly, substantiate claims with evidence, address audience-specific priorities, and compel people to take action. The difference between collateral that accelerates sales cycles and those materials that gather dust reflects whether founders understand stakeholder decision criteria, maintain regulatory compliance, and design for genuine sales utility.

Articulating unique value propositions and key benefits

Your marketing collateral needs to communicate why your device matters and what makes it different from the alternatives. Generic claims about quality or innovation fail to capture attention in the markets. So, lead with the specific problem your device solves using quantified language that stakeholders will easily recognise. If you reduce complications, specify which complications, at what rate they currently occur (and what burden they create). If you improve efficiency, quantify the current procedure time and cost per case. If you enhance accuracy, document current error rates and downstream consequences.

Next. Turn features into benefits that matter to decision-makers. Technical specifications mean nothing without context. A smaller device profile will benefit patients through reduced invasiveness and benefit hospitals with lower complication rates. Faster procedure time benefits clinicians through improved workflow and facilities through increased case volume. Every feature should connect to tangible outcomes that stakeholders care about.

Competitive differentiation requires specificity. Rather than claiming better outcomes, quantify the magnitude of improvement with supporting evidence. Structure collateral to communicate key messages quickly through executive summaries, bold headlines, pull quotes, and visual elements, to ensure you draw attention to critical information. Your words count.

Substantiating claims with clinical evidence and data

Every claim in marketing collateral requires evidentiary support, and clinical trial results provide the strongest support for these claims. When you reference specific studies by name, publication venue, and key findings, you can also specify primary endpoints, sample sizes, statistical significance, and effect magnitudes. Link these claims directly to evidence and avoid exaggeration or extrapolation beyond your published findings. Real-world evidence supplements trial data by demonstrating sustained performance outside of controlled research conditions through registry data, post-market surveillance results, and health system implementation experiences.

Economic analyses that quantify your value propositions will require rigorous methodology. Cost-effectiveness studies, budget impact models, and return on investment calculations should employ transparent assumptions, conservative estimates, and sensitivity analyses. Visual data presentation through graphs, charts, and infographics communicates complex evidence more effectively than heavy text and ensures complete accuracy (without manipulation).

Marketing collateral in the medical world lives or dies on evidentiary quality. Clinicians and payers evaluate collateral with the same critical lens they apply to journal articles. Device companies that seek to earn stakeholder trust present evidence transparently, acknowledge limitations honestly, and substantiate every claim with robust data.

_{Professor Kalipso Chalkidou. Director of Global Health Policy at the Centre for Global Development}

Tailor the message and format to target audiences

Effective collateral speaks to specific stakeholder priorities using appropriate formats and language. Clinician-focused collateral emphasises clinical outcomes, procedural advantages, and peer validation through technical specifications, mechanism of action explanations, and procedural technique details. Include peer-reviewed publication references, key opinion leader endorsements, and clinical case examples.

Administrative and procurement collateral prioritise economic value and operational impact. Lead with return on investment, cost savings through complication reduction, efficiency gains, and reimbursement coverage. Include total cost of ownership analyses comparing your device to alternatives through white papers, business cases, and executive briefing documents.
Payer collateral addresses cost-effectiveness and population health outcomes through budget impact models, cost-per-outcome analyses, and real-world effectiveness evidence. So, reference your health technology assessments, coverage policies, and reimbursement pathways formatted as evidence dossiers or health economic reports.

Patient collateral will require accessible language in an empathetic tone. Talk about device benefits by maintaining a focus on symptom relief, recovery time, and quality of life improvements using plain language. Include explanatory diagrams and frequently asked questions through brochures, educational videos, and website content.

Sales team collateral provides conversation frameworks and objection-handling tools, including competitive comparison charts, clinical evidence summaries, economic value calculators, and responses to common objections through one-page sell sheets, leave-behind folders, and digital presentations.

The biggest mistake is when people create beautiful materials that sales teams don’t use. Collateral designers who focus on aesthetic appeal often miss practical sales utility. Effective collateral functions as a sales conversation tool that addresses real objections, provides evidence at decision moments, and guides stakeholders through purchase rationale.

_{Simon Shepherd. Former VP Marketing. Smith & Nephew}

Regulatory compliance

Medical device marketing collateral needs to comply with promotional regulations that govern claims and evidence presentation. Limit your claims to approved indications and labelling. Off-label promotion will violate these regulations. Every benefit claim should trace directly to approved labelling or peer-reviewed evidence supporting on-label use.

Balance any positive claims with appropriate disclosures. For example, if you claim benefits, acknowledge material limitations or relevant risks. Fair balance demands honest, complete information that enables informed decision-making. Substantiate comparative claims rigorously through head-to-head evidence directly comparing devices (unsubstantiated competitive claims will invite legal challenges and regulatory scrutiny). Include required disclosures and disclaimers with specific language about indications, contraindications, or warnings. Obtain regulatory and legal review before publishing materials to ensure utmost compliance.

Effective collateral will guide your stakeholders toward specific next steps through clear calls to action. While early-stage awareness materials can encourage whitepaper downloads or webinar registration, mid-stage consideration materials should promote product demonstrations or consultations with clinical specialists. Late-stage decision materials should focus on purchase facilitation through pricing discussions or implementation planning.

Make your calls to action (CTA) prominent and specific. Action-oriented language like ‘schedule a 30-minute product demonstration’ generates more response than vague suggestions like ‘contact us for more information.’ Visually distinct buttons, simplified contact mechanisms, and multiple action options accommodating different stakeholder preferences all improve response rates.

The VP collateral workshop

Marketing collateral determines whether sales teams have the tools needed to communicate value effectively and guide stakeholders toward purchase decisions. We can help you find better ways to articulate unique value propositions with specificity, avoiding generic claims, substantiate every assertion with clinical evidence that withstands scrutiny, and tailor your messaging and format to specific audiences by addressing their distinct priorities. By ensuring regulatory compliance, avoiding claims or omissions that invite enforcement action, and including clear calls to action guiding stakeholders toward next steps, your collateral quality will help achieve commercial success to help people benefit from your innovation.

Waypoint checklist

Keep in mind the following suggestions when developing your marketing collateral:

• Clearly articulate your device's unique value proposition and key benefits
• Ensure all claims are supported by strong clinical evidence and data
• Tailor the messaging and format to the specific target audience
• Comply with all relevant regulatory requirements for advertising and promotion
• Include a clear and compelling call to action